医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Fortive Announces Leadership Appointments

2021年05月07日 AM05:15
このエントリーをはてなブックマークに追加


 

EVERETT, Wash.

Fortive Corporation (“Fortive”) (NYSE: FTV) announced today that both Justin McElhattan and Tami Newcombe have been promoted to Group President within Fortive.

Mr. McElhattan joined Fortive in connection with Fortive’s acquisition of Industrial Scientific Corporation (ISC) in 2017, where he has served as President since 2007. As President of ISC, Mr. McElhattan has led the growth and profitability of Fortive’s Environmental Health and Safety (EHS) businesses with the acquisitions of Intelex, SAFER Systems, and ehsAI, and the expansion of ISC’s iNet offerings to promote the safety of both customers and the community. As Group President, Mr. McElhattan will drive the results, innovation, and growth of our EHS businesses.

Ms. Newcombe has served in a series of progressive roles, including most recently as President of Tektronix, where she leverages her deep understanding of customer workflows and her passionate commitment to the Fortive Business System (FBS) to deliver results and drive significant improvements across all aspects of Fortive’s business at Tektronix. As part of her expanded responsibilities within Fortive, Ms. Newcombe will oversee Fortive’s business operations in India. She will also serve as Chair of the Fortive Inclusion & Diversity (I&D) Council, demonstrating her commitment to deepening Fortive’s strong and inclusive culture.

Mr. Lico stated, “Justin’s leadership in our enterprise-wide, connected worker strategy has been critical to taking us beyond gas detection to accelerate our strategy in EHS. His commitment to FBS has been critical to driving results, innovation, and continuous improvement across our EHS businesses.”

“Tami personifies one of our core leadership competencies, Building Extraordinary Teams, demonstrating the ability to inspire, develop, and drive engagement across our global team while accelerating innovation and growth within Tektronix,” Mr. Lico added.

The appointments highlight these leaders’ continued focus on shaping the strategy and investment areas for their businesses, championing the Fortive Business System (FBS) to drive strong operating results and foster a growth mindset, while building extraordinary teams by recruiting and developing exceptional talent.

Fortive will be holding an Investor Conference on May 19th where they will highlight key segment growth strategies, the way they are expanding the impact from FBS across the portfolio, and their commitment to sustainability. Learn more here.

ABOUT FORTIVE

Fortive is a provider of essential technologies for connected workflow solutions across a range of attractive end-markets. Fortive’s strategic segments – Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions – include well-known brands with leading positions in their markets. The company’s businesses design, develop, service, manufacture, and market professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions. Fortive is headquartered in Everett, Washington and employs a team of more than 17,000 research and development, manufacturing, sales, distribution, service and administrative employees in more than 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System. For more information please visit: www.fortive.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210506006154/en/

CONTACT

Griffin Whitney

Vice President, Investor Relations

Fortive Corporation

6920 Seaway Boulevard

Everett, WA 98203

Telephone: (425) 446-5000

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • DKT International Implements Traditional and New Forms of Marketing in Africa, South America, and Southeast Asia to Expand Access to Contraceptives
  • オルガノンが計画外妊娠をめぐり世界規模の対話の喚起を目指す
  • IHMA Opens Microbiology Reference Laboratory in Shanghai, China to Further Support Global Anti-Infective Product Discovery and Development
  • Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development
  • Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries